VA Senate · SB 257

Health insurance; requirements for certain opioid antagonists.

In plain English (AI summary)

This legislation strengthens access to life-saving medication by requiring health insurance carriers in Virginia to cover opioid antagonists, such as Naloxone, without imposing prior authorization requirements. By mandating that these reversal agents be covered as a standard benefit, the law aims to remove financial and administrative barriers for residents at risk of an opioid overdose or those seeking to be prepared for emergencies. For Arlington families and healthcare providers, this ensures that cost is no longer a deterrent to obtaining medication that can prevent fatal overdoses. The measure is expected to improve public health outcomes by increasing the availability of emergency treatment across the community, facilitating faster response times during crisis situations, and ultimately helping to save lives amid the ongoing opioid epidemic.

View original bill

Roll-call votes

Roll call
Mar 12, 2026 · VA House · pass
96 – 0 · 3 other
Full roll call
Concur House Substitute
Mar 12, 2026 · VA Senate · pass
39 – 1
Full roll call
Reported from Labor and Commerce with substitute
Feb 26, 2026 · VA House · pass
21 – 0 · 1 other
Arlington delegation
Full roll call
Passage
Feb 16, 2026 · VA Senate · pass
37 – 1 · 2 other
Arlington delegation
Full roll call
Constitutional reading dispensed
Feb 12, 2026 · VA Senate · pass
40 – 0
Arlington delegation
Full roll call
Reported from Finance and Appropriations
Feb 11, 2026 · VA Senate · pass
15 – 0
Arlington delegation
Full roll call